-
Acheson NH, Tamm I, 1967: Replication of Semliki Forest Virus: an electron microscopic study[J]. Virol, 32, 128-143. doi: 10.1016/0042-6822(67)90261-9
-
Anwanwan D, Singh SK, Singh S, Saikam V, Singh R, 2020: Challenges in liver cancer and possible treatment approaches[J]. Biochim Biophys Acta Rev Cancer, 1873, 188314-. doi: 10.1016/j.bbcan.2019.188314
-
Cai J, Lin Y, Zhang H, Liang J, Tan Y, Cavenee WK, Yan G, 2017: Selective replication of oncolytic virus M1 results in a bystander killing effect that is potentiated by Smac mimetics[J]. Proc Natl Acad Sci USA, 114, 6812-6817. doi: 10.1073/pnas.1700357114
-
Cossart P, Helenius A, 2014: Endocytosis of Viruses and Bacteria[J]. Cold Spring Harb Perspect Biol, 6, a016972-a016972. doi: 10.1101/cshperspect.a016972
-
DeTulleo L, Kirchhausen T, 1998: The clathrin endocytic pathway in viral infection[J]. EMBO J, 17, 4585-4593. doi: 10.1093/emboj/17.16.4585
-
Eissa IR, Bustos-Villalobos I, Ichinose T, Matsumura S, Naoe Y, Miyajima N, Morimoto D, Mukoyama N, Zhiwen W, Tanaka M, Hasegawa H, Sumigama S, Aleksic B, Kodera Y, Kasuya H, 2018: The current status and future prospects of oncolytic viruses in clinical trials against melanoma, glioma, pancreatic, and breast cancers[J]. Cancers (Basel), 10, 356-. doi: 10.3390/cancers10100356
-
Forrester NL, Palacios G, Tesh RB, Savji N, Guzman H, Sherman M, Weaver SC, Lipkin WI, 2012: Genome-scale phylogeny of the alphavirus genus suggests a marine origin[J]. J Virol, 86, 2729-2738. doi: 10.1128/JVI.05591-11
-
Frolova EI, Gorchakov R, Pereboeva L, Atasheva S, Frolov I, 2010: Functional sindbis virus replicative complexes are formed at the plasma membrane[J]. J Virol, 84, 11679-11695. doi: 10.1128/JVI.01441-10
-
Grimley PM, Berezesky IK, Friedman RM, 1968: Cytoplasmic structures associated with an arbovirus infection: loci of viral ribonucleic acid synthesis[J]. J Virol, 2, 1326-1338. doi: 10.1128/JVI.2.11.1326-1338.1968
-
Hang Z, Wei Y, Zhao X, 1996: Electron microscopic observation of hepato cellular carcinoma in 15 cases-an ultrastructural comparison with human embryonic liver[J]. Hua Xi Yi Ke Da Xue Xue Bao, 27, 332-336.
-
Kääriäinen L, Keränen S, Lachmi B, Söderlund H, Tuomi K, Ulmanen I, 1975: Replication of Semliki Forest Virus[J]. Med Biol, 53, 342-351.
-
Kallio K, Hellstrom K, Jokitalo E, Ahola T, 2016: RNA replication and membrane modification require the same functions of alphavirus nonstructural proteins[J]. J Virol, 90, 1687-1692. doi: 10.1128/JVI.02484-15
-
Kimanius D, Forsberg BO, Scheres SH, Lindahl E, 2016: Accelerated cryo-EM structure determination with parallelisation using GPUs in RELION-2[J]. Elife, 5, e18722-. doi: 10.7554/eLife.18722
-
Lim EXY, Lee WS, Madzokere ET, Herrero LJ, 2018: Mosquitoes as suitable vectors for alphaviruses[J]. Virus, 10, 84-. doi: 10.3390/v10020084
-
Lin Y, Zhang H, Liang J, Li K, Zhu W, Fu L, Wang F, Zheng X, Shi H, Wu S, Xiao X, Chen L, Tang L, Yan M, Yang X, Tan Y, Qiu P, Huang Y, Yin W, Su X, Hu H, Hu J, Yan G, 2014: Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers[J]. Proc Natl Acad Sci USA, 111, E4504-E4512. doi: 10.1073/pnas.1408759111
-
Lundstrom K, 2014: Alphavirus-based vaccines[J]. Virus, 6, 2392-2415. doi: 10.3390/v6062392
-
Lundstrom K, 2016: Alphavirus vectors as tools in neuroscience and gene therapy[J]. Virus Res, 216, 16-25. doi: 10.1016/j.virusres.2015.08.015
-
Lundstrom K, 2017: Oncolytic alphaviruses in cancer immunotherapy[J]. Vaccin, 5, 9-. doi: 10.3390/vaccines5020009
-
Markoff L (2015) Chapter 153 - Alphaviruses. In: Bennett JE, Dolin R, Blaser ML (eds) Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 8th edn. Elsevier, Philadelphia, pp 1865-1874.e2
-
Marks M, Marks JL, 2016: Viral arthritis[J]. Clin Med, 16, 129-134. doi: 10.7861/clinmedicine.16-2-129
-
Mendes A, Kuhn RJ, 2018: Alphavirus Nucleocapsid Packaging and Assembly[J]. Virus, 10, 138-. doi: 10.3390/v10030138
-
Pol J, Kroemer G, Galluzzi L, 2016: First oncolytic virus approved for melanoma immunotherapy[J]. Oncoimmunol, 5, e1115641-. doi: 10.1080/2162402X.2015.1115641
-
Raja J, Ludwig JM, Gettinger SN, Schalper KA, Kim HS, 2018: Oncolytic virus immunotherapy: future prospects for oncology[J]. J Immunother Cancer, 6, 140-. doi: 10.1186/s40425-018-0458-z
-
Ribas A, Dummer R, Puzanov I, VanderWalde A, Andtbacka RHI, Michielin O, Olszanski AJ, Malvehy J, Cebon J, Fernandez E, Kirkwood JM, Gajewski TF, Chen L, Gorski KS, Anderson AA, Diede SJ, Lassman ME, Gansert J, Hodi FS, Long GV, 2017: Oncolytic virotherapy promotes intratumoral T cell infiltration and improves anti-PD-1 immunotherapy[J]. Cell, 170, 1109-1119.e10. doi: 10.1016/j.cell.2017.08.027
-
Soonsawad P, Xing L, Milla E, Espinoza JM, Kawano M, Marko M, Hsieh C, Furukawa H, Kawasaki M, Weerachatyanukul W, Srivastava R, Barnett SW, Srivastava IK, Cheng RH, 2010: Structural evidence of glycoprotein assembly in cellular membrane compartments prior to alphavirus budding[J]. J Virol, 84, 11145-11151. doi: 10.1128/JVI.00036-10
-
Spuul P, Balistreri G, Kääriäinen L, Ahola T, 2010: Phosphatidylinositol 3-kinase-, actin-, and microtubule-dependent transport of Semliki Forest Virus replication complexes from the plasma membrane to modified lysosomes[J]. J Virol, 84, 7543-7657. doi: 10.1128/JVI.00477-10
-
Strauss JH, Strauss EG, Kuhn RJ, 1995: Budding of alphaviruses[J]. Trends Microbiol, 3, 346-350. doi: 10.1016/S0966-842X(00)88973-8
-
Tan Y, Lin Y, Li K, Xiao X, Liang J, Cai J, Guo L, Li C, Zhu W, Xing F, Mai J, Gu J, Tan X, Yin W, Lu B, Qiu P, Su X, Gao M, Hu J, He S, Lu L, Gong S, Yan G, Zhang H, 2018: Selective antagonism of Bcl-xL potentiates M1 oncolysis by enhancing mitochondrial apoptosis[J]. Hum Gene Ther, 29, 950-961. doi: 10.1089/hum.2017.055
-
Tang G, Peng L, Baldwin PR, Mann DS, Jiang W, Rees I, Ludtke SJ, 2007: EMAN2: an extensible image processing suite for electron microscopy[J]. J Struct Biol, 157, 38-46. doi: 10.1016/j.jsb.2006.05.009
-
Taylor A, Herrero LJ, Rudd PA, Mahalingam S, 2015: Mouse models of alphavirus-induced inflammatory disease[J]. J Gen Virol, 96, 221-238. doi: 10.1099/vir.0.071282-0
-
Weaver SC, Paessler S (2009) Chapter 21-alphaviral encephalitides. In: Barrett ADT, Stanberry LR (eds) Vaccines for biodefense and emerging and neglected diseases. Academic Press, London, pp 339–359
-
Zhang H, Li K, Lin Y, Xing F, Xiao X, Cai J, Zhu W, Liang J, Tan Y, Fu L, Wang F, Yin W, Lu B, Qiu P, Su X, Gong S, Bai X, Hu J, Yan G, 2017: Targeting VCP enhances anticancer activity of oncolytic virus M1 in hepatocellular carcinoma[J]. Sci Transl Med, 9, eaaam7996-. doi: 10.1126/scitranslmed.aam7996
-
Zhang H, Lin Y, Li K, Liang J, Xiao X, Cai J, Tan Y, Xing F, Mai J, Li Y, Chen W, Sheng L, Gu J, Zhu W, Yin W, Qiu P, Su X, Lu B, Tian X, Liu J, Lu W, Dou Y, Huang Y, Hu B, Kang Z, Gao G, Mao Z, Cheng SY, Lu L, Bai XT, Gong S, Yan G, Hu J, 2016: Naturally existing oncolytic virus m1 is nonpathogenic for the nonhuman primates after multiple rounds of repeated intravenous injections[J]. Hum Gene Ther, 27, 700-711. doi: 10.1089/hum.2016.038
-
Zhang R, Hryc CF, Cong Y, Liu X, Jakana J, Gorchakov R, Baker ML, Weaver SC, Chiu W, 2011: 4.4 Å cryo-EM structure of an enveloped alphavirus Venezuelan equine encephalitis virus[J]. EMBO J, 30, 3854-3863. doi: 10.1038/emboj.2011.261